ARENA PHARMACEUTICALS INC's ticker is ARNA and the CUSIP is 040047607. A total of 167 filers reported holding ARENA PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is 1.05 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $643,000 | +37.4% | 6,927 | +2.6% | 0.00% | 0.0% |
| Q1 2021 | $468,000 | +70.2% | 6,749 | +88.4% | 0.00% | – |
| Q4 2020 | $275,000 | +100.7% | 3,583 | +95.6% | 0.00% | – |
| Q3 2020 | $137,000 | -17.0% | 1,832 | -30.3% | 0.00% | – |
| Q2 2020 | $165,000 | +432.3% | 2,628 | +284.8% | 0.00% | – |
| Q4 2019 | $31,000 | -91.1% | 683 | -91.0% | 0.00% | -100.0% |
| Q3 2019 | $348,000 | +866.7% | 7,624 | +1115.9% | 0.00% | – |
| Q2 2019 | $36,000 | -82.4% | 627 | -88.1% | 0.00% | -100.0% |
| Q4 2018 | $205,000 | +11.4% | 5,281 | +32.0% | 0.00% | 0.0% |
| Q3 2018 | $184,000 | -53.4% | 4,000 | -55.9% | 0.00% | -50.0% |
| Q2 2018 | $395,000 | -57.8% | 9,074 | -61.7% | 0.00% | -95.1% |
| Q1 2018 | $935,000 | +79.8% | 23,682 | +54.6% | 0.04% | +86.4% |
| Q4 2017 | $520,000 | +27.5% | 15,317 | -4.3% | 0.02% | +29.4% |
| Q3 2017 | $408,000 | +2814.3% | 16,005 | +1712.6% | 0.02% | +1600.0% |
| Q2 2017 | $14,000 | – | 883 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 139,528 | $6,083,000 | 4.46% |
| Eversept Partners, LP | 134,151 | $5,848,984 | 2.68% |
| DAFNA Capital Management LLC | 95,242 | $4,153,000 | 1.94% |
| GREAT POINT PARTNERS LLC | 302,000 | $13,167,000 | 1.82% |
| Atika Capital Management LLC | 190,000 | $8,284,000 | 1.59% |
| Crawford Lake Capital Management, LLC | 205,600 | $8,964,000 | 1.57% |
| Crawford Lake Capital Management, LLC | 205,688 | $8,968,000 | 1.57% |
| Cormorant Asset Management, LP | 450,000 | $19,620,000 | 1.45% |
| SENZAR ASSET MANAGEMENT, LLC | 11,123 | $485,000 | 1.40% |
| Rhenman & Partners Asset Management AB | 284,621 | $12,409,000 | 1.27% |